Graphical Abstract Highlights Clinical integration gap: GLP-1 receptor agonists address the metabolic roots of PCOS, yet fertility-centered pathways remain inconsistent due to limited reproductive endpoint data and periconception safety concerns
reported the case of a 42-year-old patient who had been on semaglutide for weight loss for 2 months prior to undergoing an EGD for Barretts esophagus
In a head-to-head trial against a full-strength GLP-1 drug, tirzepatide reduced food craving without changing measured restraint. Slower stomach emptying also makes smaller portions feel filling for longer. People whose eating was driven by stress, reward, or constant mental effort often describe the quiet as relief
For now, he says, the jury is out on whether GLP-1s could offer any athletic advantage
Drucker elaborates, The strange thing is that you cant find many GLP-1 receptors in all these other organs where GLP-1 seems to work. This observation led to the realization that the brain, abundant in GLP-1 receptors, plays a crucial role in mediating the drugs effects